Các thể sa sút trí tuệ khác và bệnh Alheimer: Phần 2

Nối tiếp nội dung phần 1 Tài liệu Bệnh Alheimer và các thể sa sút trí tuệ khác, phần 2 giới thiệu tới người đọc các nội dung: Bệnh Alheimer, suy giảm nhận thức nhẹ, rối loạn nhận thức do mạch máu, sa sút trí tuệ thùy trán - thái dương,... Mời các bạn cùng tham khảo nội dung chi tiết.
Nội dung trích xuất từ tài liệu:
Các thể sa sút trí tuệ khác và bệnh Alheimer: Phần 2 Ateheime^s disease: a PET follow-up study. Eur J Núc! Med Moi Imaging 30:1104-1113, 200324. Du ÁT, Schuff N , Kramer J H , et ai: Different regional pattems of cortical thinning in Ateheimer^s disease and írontotemporal dementia. Brain 130:1159-1166,200725. Edelman RR, Sievvert B, Darby DG, et ai: Qualitative mapping of cerebral blood flow and íunctional localization with echoplanar MR imaging and signal targeting with alternating radio trequency. Radiology 192:513-520, 199426. Eidelberg D, Dhavvan V, Moeller JR, et ai: The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomographỵ. J Neurol Neurosurg Psychiatry 5 4 : 8 5 6 - 862,199127. Engler H, Santillo AF, Wang s x , et ai: In vivo amyloid imaging with PET in trontotemporal dementia. Eur J Nucl Med Moi Imaging 35:100-106, 200828. Fazekas F, Kleinert R, Offenbacher H , et ai: Pathologic correlates of incidental MRI vvhite matter signal hyperíntensities. Neurology 4 3 : 1 6 8 3 - 1689,199329. Fein G, Di Sclaíani V, Tanabe J, et ai: Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 55:1626-1635, 200030. Finkenstaedt M , Szudra A, Zerr I, et ai: MR imaging of Creutzfeldt-Jakob disease. Radiology 199:793-798, 199631. Fletcher PT, Povvell s, Foster NL, et ai: Quantiíying metabolic asymmetry modulo structure in Ateheimei^s disease. Inf Process Med Imaging 20:446-457, 200732. Forsberg A, Engler H , Almkvist 0 , et ai: PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29:1456-1465, 200833. Foster NL, Gilman s, Berent s, et ai: Cerebral hypometabolism in progressive supranuclear palsỵ studied with positron emission tomography. Ann Neurol 24:399-406,198834. Foster NL, Koeppe RE, Giordani BJ, et ai: Variations of the phenotype in írontotemporal dementias, in Genotype-Proteotype-Phenotype 149 Relationships in Neurodegenerative Diseases. Edited by Cummings J, Hardy J, Poncet M, et ai. Berlin: Springer-Verlag, 2005, pp 139-15235. Foster NL, Heidebrink JL, Clark C M , et ai: FDG-PET improves accuracy in distinguishing írontotemporal dementia and Ateheimer^s disease. Brain 130:2616-2635,200736. Frisoni GB, Testa c , Zorzan A, et ai: Detection of grey matter loss in mild Ateheimei^s disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 73:657-664, 200237. Gado M , Hughes CP, Danziger w , et ai: Volumetric measurements of the cerebrospinal fluid spaces in demented subjects and controls. Radiology 144:535-538, 198238. Gearing M, Mirra s s , Hedreen JC, et ai: The Consortium to Establish a Registry for Ateheimer^s disease (CERAD), part X: neuropathology contirmation of the clinical diagnosis of Ateheimei^s disease. Neurology 45:461-466, 199539. Gorno-Tempini ML, Dronkers NF, Rankin KP, et ai: Cognition and anatomy in three variants of primary progressive aphasia. A n n Neurol 55:335-346, 200440. Grundman M , Sencakova D, Jack CR, et ai: Use of brain MRI volumetric analỵsis in a mild cognitive impairment thai to delay the diagnosis of Ateheimei^s disease, in Drug Discovery and Development f o r Ateheimei^s Disease 2000. Edited by Fillet H , 0Connell A. New York Springer, 2001, pp 2 4 - 3 241. Haacke EM, DelProposto zs, Chaturvedi s, et ai: Imaging cerebral amyloid angiopathy with susceptibility-vveighted imaging. A J N R A m J Neuroradiol 28:316-317, 200742. Herholz K, Salmon E, Perani D, et ai: Discrimination betvveen Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17:302-316, 200243. Hodges JR, Patterson K: Semantic dementia: a unique clinicopathological syndrome. Lancet Neurol 6:1004-1014, 200744. Hoffman JM, VVelsh-Bohmer KA, Hanson M, et ai: FDG PET imaging in patients with pathologically verified dementia. J Nucl Med 41:1920-1928 200015045. Ishii K, Imamura T, Sasaki M, et ai: Regional cerebral glucose metabolism in dementia with Lewy bodies and Ateheimer^s disease. Neurology 51:125-130,199846. Kantarci K, Petersen RC, Boeve BF, et ai: 1H MR spectroscopy in common dementias. Neurology 63:1393-1398, 200447. Klunk W E , Engler H, Nordberg A, et ai: Imaging brain amyloid in Ateheimei^s disease with Pittsburgh Compound-B. Ann Neurol 55:306- 319, 200448. Knopman DS, DeKosky S ĩ , Cummings J L, et ai: Practice parameter: diagnosis of dementia (an evidence-based revievv). Re ...